Prenetics will explore digital asset adoption and Bitcoin financial strategies
ChainCatcher news, Nasdaq-listed company Prenetics announced the transfer of its ownership in ACT Genomics Holdings Company Limited to Delta Electronics, Inc. for $71.78 million, bringing the company's cash reserves to approximately $86 million, with expected cash and short-term assets of $117 million. The company maintains a zero-debt balance sheet, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.






